2026-01-18 - Analysis Report
**KLA Corp (KLAC) Financial Report**

**Company Overview**
KLA Corp is a leading provider of process control and yield management solutions for the semiconductor and data storage industries.

**Return Rate Comparison**

* Cumulative return of review stock: 236.60%
* Cumulative return of comparison stock (S&P 500, VOO): 93.36%
* Divergence: 143.24% (simply the difference)
* Relative divergence: 100.00% (indicates the current position when the minimum-maximum fluctuation range is set to 100)

The review stock has significantly outperformed the S&P 500 over the cumulative period.

**Alpha, Beta Analysis**

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
|------|------|------|-------|------|-------|
| 2016-2018 | 2.0% | 26.5% | -2.0% | 1.3 | 11.8B |
| 2017-2019 | 42.0% | 26.5% | 25.0% | 1.6 | 23.5B |
| 2018-2020 | 40.0% | 26.5% | 19.0% | 1.5 | 34.1B |
| 2019-2021 | 70.0% | 26.0% | 27.0% | 1.5 | 56.6B |
| 2020-2022 | 6.0% | 39.3% | 8.0% | 1.5 | 49.6B |
| 2021-2023 | -4.0% | 39.3% | -5.0% | 1.7 | 76.5B |
| 2022-2024 | -12.0% | 36.0% | -32.0% | 1.8 | 83.0B |
| 2023-2025 | 115.0% | 34.9% | 53.0% | 1.9 | 160.0B |

The review stock has experienced varying levels of performance across different time periods, with some years seeing significant growth and others experiencing decline.

**Recent Stock Price Fluctuations**

* Close: $1,567.82
* 5-day SMA: $1,483.45
* 20-day SMA: $1,340.08
* 60-day SMA: $1,237.55
* The review stock has experienced a slight increase over the last 5 days.

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**

* Market Risk Indicator (MRI): 0.80 (Medium Investment)
* RSI: 75.16 (oversold)
* PPO: 1.58
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium
* Recent (20 days) relative divergence change: 11.90 (+): improving
* 7-day Rank change: -12 (-): rank down
* 7-day Dynamic Expected Return change: 0.00 (0): flat
* Expected Return (%): 6.90%
* There appears to be a sharp rebound in the review stock, reflecting a fluctuation issue.

**Recent News & Significant Events**

* KLA Jumps 96% in a Year: Is There More Room for the Stock to Grow? - Zacks Investment Research (link)
* $KLAC stock is up 7% today. Here's what we see in our data. - Quiver Quantitative (link)
* What Is Happening With KLA Stock? - Trefis (link)
* KLA (KLAC) is “Terrific,” Says Jim Cramer - Yahoo Finance (link)
* Why Is KLA Corporation (KLAC) Stock Soaring Today - The Globe and Mail (link)
* Subdued Growth No Barrier To KLA Corporation (NASDAQ:KLAC) With Shares Advancing 32% - simplywall.st (link)

These news articles suggest that the review stock has experienced significant growth and may continue to do so.

**Analyst Opinions**

Analyst Consensus:

- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.03 (~Buy)
- Opinions: 29
- Target Price (avg/high/low): 1438.24 / 1800.00 / 1000.00

The analyst consensus suggests a buy recommendation with a target price range.

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|-----|-----|---------|
| 2025-10-31 | 8.51 | $3.21B |
| 2025-05-01 | 8.21 | $3.06B |
| 2025-01-31 | 6.18 | $3.08B |
| 2024-10-31 | 7.05 | $2.84B |
| 2025-10-31 | 7.05 | $2.84B |

The review stock has experienced varying levels of earnings and revenue across different periods.

**Financial Information = Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $3.21B | 61.27% |
| 2025-06-30 | $3.17B | 61.97% |
| 2025-03-31 | $3.06B | 61.62% |
| 2024-12-31 | $3.08B | 60.30% |
| 2024-09-30 | $2.84B | 59.62% |

The review stock has experienced consistent profit margins across different quarters.

**Financial Information = Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $4.99B | 22.49% |
| 2025-06-30 | $4.69B | 25.63% |
| 2025-03-31 | $4.00B | 27.18% |
| 2024-12-31 | $3.58B | 23.00% |
| 2024-09-30 | $3.56B | 26.57% |

The review stock has experienced varying levels of equity and return on equity across different periods.

**Comprehensive Analysis (Summary)**

The review stock has exhibited significant growth and variability across different time periods. The recent stock price fluctuations suggest a sharp rebound, and the RSI and PPO indicators suggest a moderate level of risk. The analyst consensus suggests a buy recommendation with a target price range. The earnings and revenue data suggest varying levels of performance across different periods. Overall, the review stock appears to be experiencing significant growth and may continue to do so.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.